Monte Rosa Therapeutics, Inc. (GLUE) Stock News & Chart

(GLUE)

Monte Rosa Therapeutics, Inc.

Stock chart and latest news for Monte Rosa Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Monte Rosa Therapeutics, Inc. News

PRO

Stock Titan

Markus Warmuth sells 5,466 shares of GLUE (NASDAQ: GLUE) under Rule 144

Apr 14, 2026 MarketBeat

Philip Nickson Sells 5,845 Shares of Monte Rosa Therapeutics (NASDAQ:GLUE) Stock

Apr 10, 2026 Yahoo Finance

Assessing Monte Rosa Therapeutics (GLUE) Valuation After MRT-2359 Data Update And New Public Offering

Mar 7, 2026 National Today

Monte Rosa Therapeutics Insider Sells Over $100K in Shares

Apr 11, 2026 TipRanks

Top Monte Rosa Therapeutics Executive Makes Notable Insider Stock Move

Apr 11, 2026 simplywall.st

The Market Doesn't Like What It Sees From Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) Revenues Yet As Shares Tumble 26%

Feb 14, 2026 Stock Titan

Edmund Dunn files Form 144 reporting GLUE (NASDAQ: GLUE) common stock sales

Apr 13, 2026 Yahoo Finance

Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains

Feb 6, 2026 MarketBeat

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Given Consensus Rating of "Moderate Buy" by Brokerages

Mar 27, 2026 simplywall.st

A Look At Monte Rosa Therapeutics (GLUE) Valuation After Johnson & Johnson MRT-2359 Trial Supply Agreement

Mar 28, 2026 Stock Titan

Insider at Monte Rosa Therapeutics (GLUE) sells 5,845 shares

Apr 10, 2026 Yahoo Finance

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Oct 29, 2025